论文信息 - Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis - 字舞流文

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

A. Roberts | M. Wadleigh | A. Tefferi | J. Gotlib | J. Kawashima | A. Pardanani | V. Gupta | L. Shao | S. Sirhan | J. Maltzman | V MNSSVKR GUPTA